Background—The goal of this statement is to review available literature and to put forth a
scientific statement on the current practice of fetal cardiac medicine, including the diagnosis …

The current approach to prenatal care, which involves visits at 16, 24, 28, 30, 32, 34 and 36
weeks and then weekly until delivery, was established 80 years ago. The high concentration …

Objective To examine the performance of the routine 11–13‐week scan in detecting fetal
non‐chromosomal abnormalities. Methods This was a retrospective study of prospectively …

Objective To examine the association between fetal major heart defects and increased
nuchal translucency thickness (NT), tricuspid regurgitation and abnormal flow in the ductus …

Among congenital malformations, heart defects are the most common type of anomaly, and
these are associated with a high perinatal, longterm morbidity and mortality. The objective of …

Objectives To assess the accuracy of fetal echocardiography at 11–13 weeks performed by
well‐trained obstetricians using a high‐frequency linear ultrasound transducer. Methods …

OBJECTIVE: To estimate the potential value of fetal assessment for tricuspid regurgitation at
11–13 weeks of gestation in the prediction of major cardiac defects. METHODS: We …

Nuchal translucency (NT) measurement between 11 and 14 weeks' gestation is an
undisputed marker for aneuploidies. When conventional karyotyping is normal, enlarged NT …

Congenital heart defects can be diagnosed during fetal life using echocardiography.
Prenatal diagnosis allows full investigation of affected fetuses for coexisting abnormalities …

Objective: To determine whether assessment of ductus venosus flow at 11–13 weeks'
gestation improves the detection rate of cardiac defects achieved by screening with nuchal …